featured
Long-Term Treatment Outcomes and Safety of Dupilumab in Patients With Bullous Pemphigoid
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review
J Am Acad Dermatol 2023 Apr 26;[EPub Ahead of Print], C Learned, SR Cohen, K Cunningham, S Alsukait, S Santiago, J Lu, M Rothe, A Nichols, D RosmarinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.